CMC Biologics
CMC Biologics A/S provides biopharmaceutical contract manufacturing services. It offers microbial fermentation and mammalian cell culture based cGMP manufacturing services, such as process development and scale-up of protein processes; and production of biopharmaceuticals for pre-clinical, clinical trials, and market supply. The company also provides consultancy in facility design, quality, and regulatory issues; technology evaluation; and analytical development and quality control services. CMC Biologics A/S was formerly known as CMC Biopharmaceuticals A/S. The company was incorporated in 2001 and is headquartered in Copenhagen, Denmark with additional offices in the United States and the United Kingdom.
Industries
Nr. of Employees
large (251-1000)
CMC Biologics
Products
Contract Development Manufacturing (CDMO) Services
Provides comprehensive services for biologics and cell & gene therapies, including development and manufacturing processes.
Bioprocess Manufacturing
Offers manufacturing services for biologics and advanced therapy medicinal products (ATMPs) using microbial fermentation and mammalian cell culture.
AGCellerate
A service offering that supports the transition from DNA to Investigational New Drug (IND) for drug substance development.
Lentiviral Vector Platform CDMO Services
Provides contract development and manufacturing services for lentiviral vectors used in gene therapies.
Adeno-Associated Viral Vector Production
Manufactures adeno-associated viral vectors for use in gene therapy applications.
Antibody Drug Conjugates (ADC) Manufacturing & Development
Offers manufacturing and development services for antibody-drug conjugates, combining antibodies with therapeutic agents.
Contract Development Manufacturing (CDMO) Services
Provides comprehensive services for biologics and cell & gene therapies, including development and manufacturing processes.
Bioprocess Manufacturing
Offers manufacturing services for biologics and advanced therapy medicinal products (ATMPs) using microbial fermentation and mammalian cell culture.
AGCellerate
A service offering that supports the transition from DNA to Investigational New Drug (IND) for drug substance development.
Lentiviral Vector Platform CDMO Services
Provides contract development and manufacturing services for lentiviral vectors used in gene therapies.
Adeno-Associated Viral Vector Production
Manufactures adeno-associated viral vectors for use in gene therapy applications.
Antibody Drug Conjugates (ADC) Manufacturing & Development
Offers manufacturing and development services for antibody-drug conjugates, combining antibodies with therapeutic agents.